Natural Biocon board accepts MD and CS resignations, withdraws appointments

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Natural Biocon board accepted resignation of MD Arunkumar Dashrathbhai Prajapati and CS Shruti Sharma effective Sep 26, 2026
  • Board withdrew prior appointments of two independent directors and one scrutinizer
  • Resignations filed with BSE under Regulation 30 of SEBI Listing Regulations
powered bylight_fuzz_icon
51974488

*this image is generated using AI for illustrative purposes only.

Natural Biocon (India) Limited board has accepted the resignation of Managing Director Arunkumar Dashrathbhai Prajapati and Company Secretary Shruti Sharma, both effective September 26, 2026. The board also withdrew three prior director and scrutinizer appointments in a significant governance reshuffle.

The resignations were formally noted at a board meeting held on October 1, 2026. Arunkumar Dashrathbhai Prajapati (DIN: 08281232) stepped down from his role as Managing Director, while Shruti Sharma (Membership No. A52723) resigned as Company Secretary. Both cessation dates align with the resignation letters dated September 26, 2026.

Withdrawal of prior disclosures

In a notable development, the board decided to treat three earlier disclosures as withdrawn and cancelled. These matters shall not be considered, acted upon, or relied upon by the company. The withdrawn items include:

  1. Appointment of Mrs. Rupal Patel as Scrutinizer for Remote E-voting and AGM voting.
  2. Appointment of Mrs. Tapasya Sheth (DIN: 10467746) as Additional Director (Non-Executive Independent Director) effective June 6, 2026.
  3. Appointment of Mrs. Minaben Shah as Additional Director (Non-Executive Independent Director) effective June 6, 2026.

Resignation details

Detail Information
Name Arunkumar Dashrathbhai Prajapati
Role Managing Director
DIN 08281232
Cessation Date September 26, 2026
Detail Information
Name Shruti Sharma
Role Company Secretary
Membership No. A52723
Cessation Date September 26, 2026

The board placed on record its appreciation for the valuable contribution and services rendered by both officials during their tenure. The intimation was filed with the BSE in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Regulatory compliance

The official communication was signed by Chaitali Maheshbhai Doshi, Director (DIN: 11930754). The filing adheres to Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. The company confirmed that no other material reasons influenced the decision to leave, citing better growth and career opportunities for Sharma.

Historical Stock Returns for Natural Biocon

1 Day5 Days1 Month6 Months1 Year5 Years
-4.95%-14.92%-38.30%-42.97%-63.62%0.0%

Who will be appointed as the interim Managing Director to ensure operational continuity following Arunkumar Dashrathbhai Prajapati's departure?

What specific strategic or compliance issues prompted the sudden withdrawal of the two independent director appointments and the scrutinizer nomination?

How will the simultaneous exit of the Managing Director and Company Secretary impact Natural Biocon's regulatory filings and governance stability in the coming quarter?

Natural Biocon sets September 5 board meeting for AGM approvals

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Board meeting scheduled for September 5, 2026
  • Agenda includes ratification of EGM resolutions from May 2024
  • Approval of Director’s and Secretarial Audit Reports for FY26
  • Fixing of AGM date, venue, and book closure dates
powered bylight_fuzz_icon
49819861

*this image is generated using AI for illustrative purposes only.

Natural Biocon has scheduled a Board of Directors meeting for September 5, 2026. The session will focus on approving the Annual General Meeting (AGM) logistics and statutory reports for the fiscal year ended March 31, 2026.

The company issued the intimation pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting is set to take place at the company’s registered office in Ahmedabad.

Agenda Items

The board will consider and approve several key resolutions during the session. The primary agenda includes:

  • Ratification of resolutions passed at the Extraordinary General Meeting held on May 23, 2024.
  • Approval of the draft Director’s Report and Secretarial Audit Report for the year ended March 31, 2026.
  • Fixing the date, time, and venue for the Annual General Meeting.
  • Deciding on dates for the closure of the Register of Members and Share Transfer Register for the annual book closure.
  • Approving the draft notice for the AGM.
  • Appointing a scrutinizer for remote e-voting and voting at the AGM.

Arunkumar Prajapati, Managing Director, signed the communication addressed to the General Manager of the Corporation Relationship Department at BSE Limited.

Historical Stock Returns for Natural Biocon

1 Day5 Days1 Month6 Months1 Year5 Years
-4.95%-14.92%-38.30%-42.97%-63.62%0.0%

What specific strategic initiatives or financial targets will be highlighted in the Director's Report for the fiscal year ended March 31, 2026?

How might the ratification of resolutions from the May 2024 Extraordinary General Meeting impact Natural Biocon's capital structure or operational governance?

Will the Secretarial Audit Report reveal any compliance discrepancies or governance improvements that could influence investor confidence?

More News on Natural Biocon

1 Year Returns:-63.62%